Inside Duke Medicine

Enterprise-Wide Planning: Programs of Distinction

Members of the Programs of Distinction committee are developing a process to highlight the best of the best among the many signature programs that define and differentiate the Duke brand at the national and international level.

The committee’s goal is to identify transformative programs that cross disciplines and are at or rapidly approaching a truly unique level with the capacity of delivering superior clinical care that is tightly integrated with cutting-edge research and innovation.

To facilitate the selection process, the committee has developed a scorecard of criteria by which programs will be evaluated. The scorecard will provide a transparent and consistent evaluation approach and enable all Duke faculty and staff to nominate programs and fully understand the vetting process.

Once the nomination phase concludes, the committee will select the programs, then move into the following phase – determining what is needed to ensure that those programs continue to be successful and, ultimately, how that success is measured.

Programs of Distinction Goals

• Develop a definition of a Program of Distinction
• Develop criteria to rank and select programs
• Assess potential programs:
  • Define opportunities for growth
  • Identify research and clinical synergies
  • Evaluate ability of programs to capitalize on existing resources
  • Evaluate opportunities for philanthropy
  • Identify barriers to success
• Identify outcome measures and an evaluation process to monitor the success of selected and future programs
• Establish mechanisms for future programs to develop into programs of distinction

Programs of Distinction Team
Chair: Danny Jacobs, M.D., Chair, Department of Surgery
Co-chair: Sally Kornbluth, Ph.D., Vice Dean for Basic Science
Co-Project Lead: David Zaas, M.D., Department of Medicine
Co-Project Lead: Momen Wahidi, M.D., Department of Medicine
David Epstein, M.D., Chair, Department of Ophthalmology
James Nunley, M.D., Chair, Department of Orthopaedic Surgery
Tony Visco, M.D., Department of Obstetrics and Gynecology
Andy Berchuck, M.D., Department of Obstetrics and Gynecology
Tommy D’Amico, M.D., Department of Surgery
Carolyn Carpenter, Duke Cancer Institute
Deb Sudan, M.D., Department of Surgery
Manesh Patel, M.D., Department of Medicine
Bart Haynes, M.D., Duke Human Vaccine Institute
Geoff Ginsburg, M.D., Ph.D., Institute for Genome Sciences and Policy
Mary Ann Fuchs, DNP, RN, Vice President of Patient Care and System Senior Nurse Executive, DUHS
Donald McDonnell, Ph.D., Chair, Department of Pharmacology and Cancer Biology
Eric Postel, M.D., Department of Ophthalmology
Steve Lisberger, Ph.D., Chair, Department of Neurobiology
Pam Sutton-Wallace, Sr. VP, Hospital Operations
Peter Grossi, M.D., Duke Neurosurgery of Raleigh
Lisa Pickett, M.D., Durham Regional Hospital
Joanne Kurtzberg, M.D., Department of Pediatrics
Ellen Medearis, VP, Medical Center Development and Alumni Affairs
Doug Stokke, Assoc. VP, Duke Medicine News and Communications

Staff
Sara Holleran
Sabrina Olsen

Consult/support
Michael Sachs – Sg2

Read more about the projects, goals and teams for each objective:

Click here for a Enterprise-Wide Planning project overview.

Click here to read more about Clinical Alignment.

Click here to read more about Optimizing Research.

Click here to read more about Redesigning Education.

Visit https://intranet.mc.duke.edu/sites/ent_plan/SitePages/Home.aspx to view an Enterprise-Wide Planning presentation by Dr. Dzau and to provide comments and questions.